Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability to diagnose cardiac disease with greater accuracy and precision
March 05, 2024
SPONSORED CONTENT: Finding the Right Solution
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability…
Read More
NIH-funded observational study shows risk grows sharply with more frequent use
March 05, 2024
Smoking Cannabis Associated with Increased Risk of Heart Attack, Stroke
March 5, 2024 — Frequent cannabis smoking may significantly increase a person’s risk for heart attack and stroke,…
Read More
Regulatory approval for the first fully integrated PFA system with a CARTO-enabled simple and reproducible workflow
March 05, 2024
Biosense Webster Announces CE Mark approval in Europe for VARIPULSE Pulsed Field Ablation (PFA) Platform
March 5, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-HF2) of its FIRE1 System for remote heart failure monitoring.
March 05, 2024
FIRE1 Completes Enrollment in US Early Feasibility Study of Innovative Remote Heart Failure Monitoring System
March 5, 2024 —  FIRE1 announced that it has completed patient enrollment in the U.S. Early Feasibility Study (FUTURE-…
Read More
During the upcoming Healthcare Information and Management Systems Society Global Conference and Exhibition, HIMSS24, experts from the world’s largest government agencies will convene to focus on the future of public healthcare and the regulation of artificial intelligence (AI) and other emerging trends.
March 05, 2024
Top Public Policy Experts at HIMSS24 to Address Global AI Landscape and Digital Transformation in Healthcare
March 6, 2024 — This year’s Healthcare Information and Management Systems Society HIMSS Global Conference and…
Read More
First coronary drug-coated balloon in U.S. provides safe, effective alternative to treat coronary in-stent restenosis and reduce risk of reoccurrence
March 01, 2024
Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon
March 1, 2024 — Boston Scientific Corporation today announced it has received U.S. Food and Drug Administration (FDA)…
Read More
Maternal stress may lead to adverse changes in mental, physical health that impact development of the fetal heart
March 01, 2024
Severe Maternal Grief Associated with Increased Risk of Heart Failure in Child
March 1, 2024 — Prenatal stress is a potential risk factor for cardiovascular disease in offspring later in life. In a…
Read More
Sumeet Chugh, MD. Photo by Cedars-Sinai
March 01, 2024
New Studies: AI Captures Electrocardiogram Patterns That Could Signal a Future Sudden Cardiac Arrest
March 1, 2024 — Two new studies by Cedars-Sinai investigators support using artificial intelligence (AI) to predict…
Read More
Five highly-anticipated late-breaking clinical trial sessions, an ACC/AHA guidelines update session and a host of featured clinical research sessions have been announced by program planners for the American College of Cardiology’s 73rd Annual Scientific Session & Expo to be held April 6-8 in Atlanta, GA.
February 29, 2024
American College of Cardiology ACC.24 Late-breaking Science and Guidelines Session Summary
February 29, 2024 — The American College of Cardiology (ACC) will soon be holding its ACC 73rd Annual Scientific…
Read More
On March 25, Diagnostic and Interventional Cardiology will present a webinar on "Maximizing Structural Heart Workflows: Harnessing the Power of CVIS and AI."
February 29, 2024
Webinar on Optimizing Structural Heart Workflows to be Rescheduled
PLEASE NOTE: This webinar has been postponed to a later date.  A new date will be posted in the coming days.    On…
Read More
New image-guided therapy system is a complete interventional solution for confident diagnosis, image guidance, and therapy assessment of patients with stroke or other neurovascular diseases
February 28, 2024
Philips Launches New Azurion Neuro Biplane System at #ECR2024 to Speed Up and Improve Minimally Invasive Diagnosis and Treatment of Neurovascular Patients
February 28, 2024 — Royal Philips, a global leader in health technology, announced major enhancements to its Image…
Read More
New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center indicates that survivors of childhood cancer are at a significantly higher risk of death following a major cardiovascular event
February 28, 2024
Long-term Survivors of Childhood Cancer at Higher Risk of Death Following Heart Issues; Threshold for Treating Risk Factors Should be Lower
February 28, 2024 — New research out of VCU Massey Comprehensive Cancer Center and VCU Health Pauley Heart Center…
Read More
American Heart Association’s first scientific statement on artificial intelligence (AI) underscores value of technology’s new clinical insights on CVD patient outcomes
February 28, 2024
Urgent Need to Develop Best Practices to Advance Use of AI in Cardiovascular Care
February 28, 2024 — Artificial intelligence (AI) may transform cardiovascular medicine. For now, though, many…
Read More
Health technology giant Royal Philips has announced its proposal to appoint Charlotte Hanneman as member of the Board of Management to fulfill the role of Chief Financial Officer (CFO), filling the position held by Abhijit Bhattacharya, who will be retiring at the end of September after in that role since 2015.
February 28, 2024
Philips Appoints Charlotte Hanneman to succeed Abhijit Bhattacharya as Chief Financial Officer (CFO)
February 28, 2024 — Royal Philips has announced the proposal to appoint Charlotte Hanneman as member of the Board of…
Read More
Gen 2 System has potential to reduce cardiac workload and enhance blood flow
February 27, 2024
Aria CV Announces First Patient Successfully Implanted with Second-Generation Pulmonary Hypertension System
February 27, 2024 — Aria CV, Inc, a developer of medical devices treating pulmonary hypertension, today announced the…
Read More
Investigational device designed for Left Atrial Appendage Elimination (LAAX) to reduce the risk of stroke in patients with non-valvular atrial fibrillation 
February 27, 2024
Biosense Webster Begins Enrollment of Pivotal Trial Evaluating the Laminar Left Atrial Appendage Elimination Device 
February 27, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson &…
Read More
The Ohio State University Wexner Medical Center is the first in central Ohio to take part in a global clinical trial to use a novel therapy to reduce the size of the left ventricle without open-heart surgery
February 26, 2024
Ohio State First in Central Ohio to Use Novel Heart Failure Therapy
February 26, 2024 — More than 6 million Americans live with heart failure, and about half have an enlarged left…
Read More
The academic medical centers earned distinguished three-star ratings from The Society of Thoracic Surgeons (STS) for their patient care and outcomes in adult cardiac surgery
February 26, 2024
Hackensack Meridian Hackensack University and Jersey Shore University Medical Centers Again Ranked Among the Elite Hospitals in North America for Open Heart Surgery
February 26, 2024 — Hackensack Meridian Jersey Shore University Medical Center and Hackensack University Medical Center…
Read More
Visualization of the blood vessels in the brain of a patient without early venous filling, meaning without excessive reperfusion of the brain area after removal of the blood clot in the blocked artery.
February 26, 2024
Arterial Connections Improve Treatment Outcomes Following Stroke
February 26, 2024 — Ischemic strokes are a major health burden. They occur when a blood vessel that supplies the brain…
Read More
FDA-cleared Cleerly ISCHEMIA will assist healthcare professionals in clinical diagnosis and decision making for coronary artery disease
February 23, 2024
Cleerly ISCHEMIA Software Device Billable With AMA Category I CPT Code for Noninvasive Estimates of Fractional Flow Reserve
February 23, 2024 — Cleerly, the company creating a new standard of care to aid in the diagnosis of heart disease,…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now